Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
25.60
-1.16 (-4.33%)
At close: Dec 17, 2025, 4:00 PM EST
25.66
+0.06 (0.23%)
Pre-market: Dec 18, 2025, 7:33 AM EST
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.53 billion as of December 18, 2025. Its market cap has increased by 15.98% in one year.
Market Cap
2.53B
Enterprise Value
1.60B
1-Year Change
15.98%
Ranking
Category
Stock Price
$25.60
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.53B, an increase of 670.35%. That is a compound annual growth rate of 41.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 2.64B | 33.80% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 949.79B |
| Johnson & Johnson | 517.18B |
| AbbVie | 401.55B |
| UnitedHealth Group | 309.80B |
| AstraZeneca | 282.48B |
| Novartis AG | 258.61B |
| Merck & Co. | 247.93B |
| Novo Nordisk | 224.22B |